These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26854929)

  • 1. T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.
    Patterson SJ; Pesenacker AM; Wang AY; Gillies J; Mojibian M; Morishita K; Tan R; Kieffer TJ; Verchere CB; Panagiotopoulos C; Levings MK
    J Clin Invest; 2016 Mar; 126(3):1039-51. PubMed ID: 26854929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation.
    Morlacchi S; Dal Secco V; Soldani C; Glaichenhaus N; Viola A; Sarukhan A
    J Immunol; 2011 Jun; 186(12):6807-14. PubMed ID: 21572026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions.
    Zou T; Caton AJ; Koretzky GA; Kambayashi T
    J Immunol; 2010 Sep; 185(5):2790-9. PubMed ID: 20686126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cells.
    Chang LY; Lin YC; Kang CW; Hsu CY; Chu YY; Huang CT; Day YJ; Chen TC; Yeh CT; Lin CY
    J Immunol; 2012 Jul; 189(2):567-74. PubMed ID: 22664873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection.
    Kaur G; Tuen M; Virland D; Cohen S; Mehra NK; Münz C; Abdelwahab S; Garzino-Demo A; Hioe CE
    Virology; 2007 Dec; 369(1):214-25. PubMed ID: 17765942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
    Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C
    J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes.
    Haque M; Lei F; Xiong X; Das JK; Ren X; Fang D; Salek-Ardakani S; Yang JM; Song J
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30777937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulatory effects of chemotherapeutic protocol on CCL3_CCL4_CCL5/CCR5 axes in acute myeloid leukemia patients with monocytic lineage.
    Yazdani Z; Mousavi Z; Ghasemimehr N; Kalantary Khandany B; Nikbakht R; Jafari E; Fatemi A; Hassanshahi G
    Life Sci; 2020 Jan; 240():117071. PubMed ID: 31783051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands.
    McAlpine SM; Issekutz TB; Marshall JS
    FASEB J; 2012 Mar; 26(3):1280-9. PubMed ID: 22125314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
    Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
    Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.
    Choi W; Li Z; Oh HJ; Im SK; Lee SH; Park SH; You IC; Yoon KC
    Curr Eye Res; 2012 Jan; 37(1):12-7. PubMed ID: 22029739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy.
    Gough M; Crittenden M; Thanarajasingam U; Sanchez-Perez L; Thompson J; Jevremovic D; Vile R
    J Immunol; 2005 May; 174(9):5766-73. PubMed ID: 15843579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis.
    Fife BT; Paniagua MC; Lukacs NW; Kunkel SL; Karpus WJ
    J Neurosci Res; 2001 Nov; 66(4):705-14. PubMed ID: 11746391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cell-induced colitis.
    Endharti AT; Okuno Y; Shi Z; Misawa N; Toyokuni S; Ito M; Isobe K; Suzuki H
    J Immunol; 2011 Jan; 186(1):41-52. PubMed ID: 21098236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
    Ikeda T; Hirata S; Fukushima S; Matsunaga Y; Ito T; Uchino M; Nishimura Y; Senju S
    J Immunol; 2010 Nov; 185(9):5259-67. PubMed ID: 20921531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
    Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
    Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.